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NTD – N-terminal domain, SDM – site directed mutant, TA – toxin-antitoxin, wHTH – 
winged helix-turn-helix  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 3 
Abstract 
Bacteria resist phage infection using multiple strategies, including CRISPR-Cas and 
abortive infection (Abi) systems. Abi systems provide population-level protection 
from phage predation, via ‘altruistic’ cell suicide. It has recently been shown that 
some Abi systems function via a toxin-antitoxin (TA) mechanism, such as the 
widespread AbiE family. The Streptococcus agalactiae AbiE system consists of a 
bicistronic operon encoding the AbiEi antitoxin and AbiEii toxin, which function as a 
Type IV TA system. Here we examine the AbiEi antitoxin, which belongs to a large 
family of transcriptional regulators with a conserved N-terminal winged-helix-turn-
helix (wHTH) domain. This wHTH is essential for transcriptional repression of the 
abiE operon. The function of the AbiEi C-terminal domain (CTD) is poorly 
characterised, but it contributes to transcriptional repression and is sufficient for toxin 
neutralization. We demonstrate that a conserved charged surface on one face of the 
CTD assists sequence-specific DNA binding and negative autoregulation, without 
influencing antitoxicity. Furthermore, AbiEi binds cooperatively to two inverted 
repeats within the abiE promoter and bends the DNA by 72. These findings 
demonstrate the mechanism of DNA binding by the widespread family of AbiEi 
antitoxins and transcriptional regulators can contribute to negative autoregulation.  
Graphical abstract 
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Introduction 
Bacteriophages (phages) are ubiquitous biological entities, numbering >1030 and 
participating in ~1025 infections every second, which affects both bacterial evolution 
and global carbon cycles [1,2]. In response to these viral threats, bacteria have 
developed multiple resistance strategies, including CRISPR-Cas ‘adaptive immunity’ 
and abortive infection (Abi) ‘innate immunity’ [3,4]. Like many phage resistance 
mechanisms, Abi systems function post-infection, typically interfering with phage 
replication. What sets Abi systems apart from other defences is that their activation 
results in the death of the infected bacterium – a form of ‘bacterial apoptosis’ [4,5]. 
This cell death, which is sometimes viewed as ‘altruistic cell suicide’, provides 
community-level protection by limiting the spread of phages through spatially 
structured bacterial populations [5,6]. Greater than 20 Abi systems have been 
identified and are predominantly plasmid-encoded in industrially-important 
lactococci. However, for most Abi systems the molecular basis of phage resistance 
remains unknown [5] . 
Recently, several Abi systems have been shown to act via a toxin-antitoxin (TA) 
mechanism [7-9] and likewise, some TA systems provide defence against phages 
[10,11]. Toxin-antitoxin (TA) systems were originally identified on plasmids, where 
they enhance maintenance by killing cells that lose the plasmid through mis-
segregation upon cell division [12,13]. TA systems require the activity of a toxin and 
an antagonistic antitoxin. Antitoxins are more labile than their cognate toxins and, 
when synthesis of both ceases (e.g. post-segregation or during phage infection), the 
antitoxin is quickly degraded, enabling the toxin to affect its target. For all known TA 
systems, the toxin component is a protein that targets essential cellular processes, 
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such as DNA replication through inhibition of DNA gyrase (e.g. CcdB) and inhibition 
of translation by cleavage of mRNAs that are either free (e.g. ToxN) or bound to the 
ribosomal A-site (e.g. RelE) [3,14,15]. Based on the mechanism of antitoxicity, six 
types of TA systems have been defined [15,16]. Type I encode small antisense 
RNAs that interact directly with the toxin mRNA and typically inhibit toxin translation 
(e.g. Hok-Sok) [12,17]. In Type II, a protein antitoxin inhibits the toxin by directly 
binding and forming an inactive TA complex (e.g. MazEF) [17-19]. An RNA antitoxin 
interacts directly with the toxic protein in Type III systems, of which ToxIN is the 
defining member [8,20]. Type IV are composed of protein toxins and antitoxins that 
do not directly interact, rather the antitoxin antagonises the toxic activity on the target 
(e.g. CbeA-CbtA) [7,21,22]. In the Type V GhoST system, a protein antitoxin 
degrades the toxin transcript, preventing toxin translation [23]. Finally, in the Type VI 
system, the SocA antitoxin promotes degradation of the SocB toxin by ClpXP [24].  
AbiE, from the group B Streptococcus agalactiae V/R 2603 is an Abi system that 
functions via a TA mechanism involving two proteins. It is encoded by a bicistronic 
operon, with the antitoxin and toxin genes overlapping by 4 bp. The first AbiE system 
was identified in Lactococcus lactis where it aborts c2 and 712 phages of the 
Siphoviridae family [25]. AbiE is a Type IV TA system as there is no apparent direct 
interaction between the antitoxin, AbiEi, and toxin, AbiEii [7]. The antitoxin and toxin 
are members of abundant protein families that are most commonly encoded from the 
same operon (some homologues are wrongly annotated as AbiGi and AbiGii, 
respectively) [7]. The AbiEii toxin is a putative nucleotidyltransferase (DUF1814) that 
specifically binds GTP. It is hypothesised that this GTP is transferred to a conserved 
cellular target(s) of the toxin, but the mechanism of toxicity remains unresolved [7]. 
DUF1814 proteins are widespread with >3000 identified, although not all encoded 
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adjacent to a putative antitoxin [7,26,27]. The AbiEi Pfam clan (CL0578) contains 
three members; AbiEi_4 (e.g. AbiEi [7]), AbiEi_3 (e.g. MosAT [28]) and AbiEi_1 (e.g. 
Rv2827c [29]), which are present in >600 species of bacteria and archaea.  
AbiEi functions as both the antitoxin and a transcriptional repressor of the abiE 
operon [7]. It is composed of an N-terminal domain (NTD) with a conserved wHTH 
DNA binding motif and a CTD containing a protein fold that has not yet been 
functionally characterized [7,29]. Autoregulation is common amongst Type II TA 
systems and can be either positive or negative [30,31]. Antitoxins from Type II TA 
systems can partially repress operon expression by binding to operators in the 
promoter region, with full repression being achieved when a complex of the antitoxin 
and toxin bind through a mechanism termed conditional cooperativity [32]. Such 
Type II antitoxins commonly have a structured N-terminal DNA-binding motif and a 
less structured C-terminus that interacts with the toxin [32]. Previous work on the S. 
agalactiae AbiE system revealed that full length AbiEi, is necessary for abiE 
repression, yet the CTD alone is sufficient for inhibition of toxicity [7]. No further 
repression is seen upon addition of the toxin, showing that the mechanism of 
autoregulation for this Type IV TA system is different to what is typically observed for 
conditional cooperativity in Type II TA systems [7].  
AbiEi is the first example of a Type IV antitoxin that regulates the expression of its 
own operon. Here, we demonstrate that a conserved positive surface charge on one 
face of the CTD is required to stabilize the interaction between AbiEi and the 
operator sites in the abiE promoter, and this occurs through base specific 
interactions with the DNA. However, this positive surface charge is not required for 
antitoxic activity. The binding of two AbiEi subunits to the operator inverted repeats 
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(IRs) is cooperative and involves changes in DNA topology upon binding. Thus, the 
widespread fold that constitutes the CTD represents a dual-function domain that can 
provide antitoxicity, while also playing an important role in DNA binding and 
transcriptional repression. 
Results 
AbiEi has a conserved positively charged surface predicted to aid DNA 
binding  
AbiEi is predicted to be composed of two functional domains: an N-terminal wHTH 
DNA-binding motif and a bifunctional CTD important for both promoter repression 
and toxin neutralization [7]. To investigate the dual functionality of the CTD, we used 
Phyre2 [33] to search for S. agalactiae AbiEi homologues with known structures. The 
top scoring candidate (98.2% confidence) was Rv2827c from Mycobacterium. 
tuberculosis (Fig. 1a), which provided a structural model for residues 4 to 155 (out of 
196) of S. agalactiae AbiEi (Fig. 1b). Rv2827c and AbiEi are members of the 
abundant COG5340 protein family and contain a conserved wHTH DNA-binding 
domain and a CTD with an arrangement of α-helices and β-sheets forming a unique 
topology [7,29]. Structural searches using just the CTD revealed that Rv2827c is the 
only solved protein containing this fold [29]. One face on the CTD of Rv2827c 
contains a patch of positive charge, which has been proposed to facilitate interaction 
with DNA (Fig. 1a) [29]; however, there is currently no experimental evidence to 
support this. A similar positively charged face was present in the S. agalactiae AbiEi 
model, suggesting this is a conserved feature of COG5340 family proteins (Fig. 1b). 
We identified 18 potential DNA-binding surface-exposed lysine and arginine residues 
in both the wHTH domain and the positively charged face of the CTD (Fig. 1c-e). 
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Aligning the wHTH domain of AbiEi with a model of Rv2827c bound to DNA [29] 
clearly demonstrated the close proximity of the positively charged face of the CTD to 
the DNA. We theorized that this charged surface would aid the AbiEi-operator site 
interaction to elicit autoregulation of the abiE operon (Fig. 1e).  
The positively charged surface cumulatively aids negative autoregulation 
To test the hypothesis that the positive surface charge of the CTD assists in 
interaction of AbiEi with inverted repeats within the abiE promoter, we mutated each 
of the surface-exposed DNA-facing lysine and arginine residues to alanine. A further 
7 residues in the C-terminal region that could not be confidently modeled with the 
Rv2827c template were also mutated (i.e. K159, K169, K170, K174, K181, K187 and 
K189). The site-directed mutants (SDMs) shown in Fig. 1c-e were tested for their 
ability to repress expression of the abiE operon using a lacZ reporter system. The 
abiE promoter region contains a perfect 11 bp palindromic repeat, which can be 
extended up to 23 bp with only 4 mismatches (Fig. 2a) [7]. Binding of AbiEi to these 
inverted repeats represses expression of the reporter gene via a negative 
autoregulation mechanism, resulting in a decrease in β-galactosidase activity (Fig. 
2a and b). Wild type (WT) AbiEi inhibited expression from the abiE promoter by ~20-
fold compared with an empty vector negative control lacking AbiEi (Fig. 2a and b). In 
wHTH proteins, the protruding recognition helix, most commonly helix 3 (H3), is 
embedded in the major groove of target DNA through many base-specific contacts 
[29,34,35] and the wing provides an interface that interacts with the minor groove 
[36]. As expected, mutation of the critical invariant H3 residue R35 (Fig. 1c) resulted 
in an almost complete loss of promoter repression, demonstrating the capability of 
the assay to detect mutants impaired in autoregulation (Fig. 2b). However, no major 
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impairment in autoregulation was observed for any of the other SDMs. We also 
examined whether mutation of these positively charged residues affected the ability 
of AbiEi to antagonise the toxicity of AbiEii, but did not detect any differences 
compared with the WT antitoxin (Fig. 2d and e). Therefore, these individual charged 
residues do not play a role in the antitoxicity function of AbiEi and another region of 
the CTD must be responsible for antitoxicity. Furthermore, because the CTD is 
required for antitoxicity [7], these results confirm that the mutations did not detectably 
impair folding or stability of the AbiEi protein.  
The lack of impaired negative autoregulation for any of the CTD SDMs led us to 
hypothesize that the surface charge might function redundantly or cumulatively and 
hence, not be sufficiently disrupted in these single mutants. We therefore 
constructed a series of double and triple SDMs to more substantially deplete the net 
positive charge on the surface of the CTD. As before, residues chosen for mutation 
were based upon the CTD face predicted to interact with DNA in the AbiEi model 
(Fig. 1), and also residues in the C-terminus that had not been possible to 
confidently model. Several double mutants, R44A:R66A, R44A:R100A, 
R66A:R100A, R97A:R100A, and a R44A:R66A:R100A triple mutant displayed 
impaired abiE repression compared with the corresponding individual SDMs (Fig. 
3a). R44 is located within the wing of the wHTH NTD (Fig. 1c and d), residues R66, 
R97 and R100 are exposed on the CTD surface and lie within close proximity to 
modelled DNA (Fig. 1e). Therefore, the loss of autoregulation by R44A:R66A, 
R44A:R100A, R66A:R100A, R97A:R100A and R44A:R66A:R100A suggests that the 
successive loss of positive charge within certain spatial regions of the CTD surface 
has an additive effect resulting in a loss of promoter repression. The K69A:R97A, 
K69A:R100A mutants were moderately impaired in promoter repression (Fig. 3), 
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therefore the K69 sidechain, which is close to one side of the predicted charged CTD 
face, appears to contribute to the interaction of AbiEi with the promoter DNA, albeit 
less than the surface-exposed arginine residues on this face. In contrast, multiple 
mutations of the far C-terminal lysine residues (i.e. K159A:K170A, K170A:K181A, 
K181A:K189A, and K170A:K181A:K189A) did not influence autoregulation, 
indicating that the unmodeled portion of the CTD is not involved in interaction with 
the abiE operator. All AbiEi mutant variants were apparently correctly folded and 
stable, as mutations of multiple positively charged residues had no effect on 
antitoxicity (Fig. 3b). Thus, the positively charged residues contribute to a net charge 
on the AbiEi surface that is important for autoregulation but do not contribute to 
antitoxicity.  
AbiEi binds cooperatively to two inverted repeats overlapping the abiE 
promoter  
The impaired ability of AbiEi mutants with depleted surface charges to negatively 
autoregulate the abiE promoter was likely due to reductions in their binding affinity 
for the abiE operators. To test this, we required a quantitative and detailed 
understanding of how WT AbiEi binds the two operators. Therefore, we performed 
electrophoretic mobility shift assays (EMSAs) using a 175 bp fluorescently labeled 
DNA probe containing 100 bp of the sequence upstream of the abiE operon, 
including both inverted repeats. WT AbiEi produced two discrete shifts (Fig. 4a). The 
binding was specific, as it could be outcompeted by addition of 100-fold excess 
unlabeled specific, but not non-specific, DNA (Fig. 4a). These single and double 
shifts likely represent occupancy of either one or both of the inverted repeat sites, 
respectively. Indeed, replacement of either IR1 or IR2 with cytosines resulted in only 
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single shifts, indicating that the second binding site had been disrupted (Fig. 4b, c 
and Fig. S1). No shift was detected when both inverted repeats were replaced with 
cytosines (Fig. 4d), further confirming the specificity of AbiEi for the inverted repeats. 
The binding of AbiEi has an apparent dissociation constant (Kd) of 10.8 ± 0.7 nM 
(Fig. 4e). The binding of AbiEi to the abiE operators exhibited strong positive 
cooperativity, which was determined via a Hill plot (nH = 2.3 ± 0.2; where a slope 
greater than one indicates cooperativity) (Fig. 4f). Cooperative binding was further 
supported by analysing the data using a Scatchard plot, where an inverted concave 
curve indicated cooperativity (Fig. 4g). Thus, AbiEi binds in a specific and 
cooperative manner to the two inverted repeats in the abiE promoter region.  
Cooperative binding by AbiEi results in DNA bending  
To further characterise the cooperative binding phenotype of AbiEi, we examined the 
role of the topology of the inverted repeat DNA. Firstly, one inverted repeat is 
sufficient for non-cooperative AbiEi binding, as a shift was detected using a 
fluorescent probe consisting of only a single 23 bp IR, demonstrating that no flanking 
DNA is required (Fig. 4h). Previous work has shown similar 23 bp inverted repeats, 
separated by three bp are found upstream of other AbiE loci [7]. To show whether 
the three bp spacing between the two inverted repeats was important for AbiEi 
binding, we tested the effect of insertion of a 50 bp spacer sequence between the 
inverted repeats. Using this IR1-spacer-IR2 probe, two discrete shifts were still 
observed (Fig. 4i). Whilst the Kd (8.9  1.4) remains similar to that of the WT probe 
(Fig. 4j), a decrease in apparent cooperativity was observed (Fig. 4k and l). 
Nonetheless, the maintenance of some cooperativity, despite the addition of the 50 
bp spacer between the operator sites, suggests that a conformational change or 
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spatial rearrangement in the DNA, such as DNA bending to loop out the intervening 
space, occurs upon AbiEi binding. To investigate this, we performed DNA bending 
EMSAs by varying the position of the WT IR1-IR2 operator region along a series of 
170 bp probes (Fig. 4m). Greater retardation of the DNA fragment mobility was 
observed when the operator region was positioned at the centre, compared to near 
either end of the DNA probes. In the absence of AbiEi, all DNA probes migrated 
similarly regardless of the operator region location, demonstrating that there is no 
intrinsic bending or difference in migration of the DNA probes themselves. The 
relative mobilities of the DNA fragments with and without AbiEi bound, and the 
position of the AbiE operator region along the probes, was used to calculate that 
AbiEi induced a 72 ± 2 bend in the operator DNA (Fig. 4n). In summary, AbiEi 
binds specifically to the two inverted repeats found in the promoter region of the AbiE 
operon. This binding is strongly cooperative when the operators are appropriately 
spaced and results in a bend of 72 in the DNA.  
The positively charged surface residues on AbiEi increase DNA binding 
affinity  
Several AbiEi variants with single alanine substitutions in amino acids that were 
predicted to interact with DNA (Fig. 1), were purified and tested for their ability to 
bind to the abiE promoter in vitro. When R35 was mutated to alanine, no discreet 
shift was detected, and consequently the Kd could not be determined (Fig. 5a and 
Fig. S2). This is in agreement with the autoregulation assay data (Fig. 2b), further 
indicating that there is no stable interaction between AbiEi R35A and the IRs. The 
single mutation of R66 to alanine resulted in no detectable change in binding affinity 
to the abiE promoter region (Fig. 5a and Fig. S2), indicated by a Kd of 8.8 ± 0.6 nM 
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(Fig. 5a and Fig. S2). Mutation of K47 and K69 to alanine resulted in decreased 
binding to the abiE promoter region, with Kd values of 21.9  6.5 and 15.4  4.3, 
respectively (Fig. 5a). These K47A and K69A variants retained cooperative binding, 
as determined through Hill and Scatchard plots (Fig. S2). Similarly, the R97A variant 
had an apparent decrease in binding affinity with a Kd of 14.4  1.7, and binding 
remained cooperative (Fig. 5a and Fig. S2). The R44A and R100A mutants exhibited 
Kd values of 19.2  4.4 nM and 9.6 ± 0.6 nM, respectively and retained cooperativity 
(Fig. 5a and Fig. S2). However, little or no discrete single shift products were 
detected (see next section). Therefore, mutation of some single charged amino acids 
resulted in reduced binding affinities of AbiEi to the WT abiE operator sites.  
Because the in vivo autoregulation experiments demonstrated that repression was 
decreased with successive mutations on the positive surface of AbiEi (Fig. 3), we 
hypothesized that these proteins would be attenuated for binding to the WT abiE 
operator. In agreement, R44A:R66A, R44A:R100A and R66A:R100A variants 
resulted in no DNA binding, indicating that a severe reduction in the positive charge 
reduces the stability of the AbiEi interaction with the operator (Fig. 5b). When 
compared with the single amino acid variants (Fig. 5a), these results further support 
that multiple positively charged residues have a cumulative effect on DNA binding. In 
summary, the positively charged surface of the CTD stabilizes the interaction of 
individual AbiEi proteins with the operator DNA leading to negative autoregulation of 
the abiE operon.  
The AbiEi CTD binds the extended region of the inverted repeats  
To further characterize AbiEi DNA binding, we examined select single mutants in 
further detail. The R44A and R100A mutants resulted in unique DNA binding profiles, 
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with no discreet single shifts detected, but an apparent double shift relating to two 
bound AbiEi proteins occurred (Fig. 5a). To investigate the AbiEi R100A and DNA 
complex further, we tested R100A using DNA probes in which either one of the two 
IRs were replaced with cytosines (Fig. 5c). In both cases, no discreet shift was 
observed, indicating that the mutated protein only formed a stable interaction with 
the native abiE operator that contains both IRs. The Hill and Scatchard plots (Fig. 
S2) demonstrated that DNA binding by R100A retained cooperativity, despite the 
inability to form a stable complex with a single IR (Fig. 5c). Therefore, the R100A 
mutant exhibits obligatory cooperative binding to the abiE operator, i.e. occupancy of 
a single inverted repeat is unstable. The obligate cooperative behaviour of AbiEi 
R100A was not the result of an altered stoichiometry in solution, because the size 
exclusion chromatogram was indistinguishable from the WT (Fig. S3). When 
compared with molecular weight standards, both proteins eluted later than a 29 kDa 
standard, indicating that AbiEi WT and R100A (27 kDa) are monomers in solution 
(Fig. S3).  
We also selected the R97A mutant that displayed reduced DNA binding affinity, but 
had cooperative binding similar to WT AbiEi (Fig. 5a). When binding of R97A to DNA 
containing either of the two IRs replaced with cytosines was tested, a strong discrete 
shift was detected only when IR2 was present (Fig. 5d). There are four differences 
between the sequences of the extended 23 bp IRs, all which lie within the extended 
central regions (Fig. 2a; red bases). This suggests that R97 contributes to base-
specific contacts with the extended central regions in the IRs, because when R97 is 
mutated to alanine it retains binding to IR2 but has a severely reduced affinity for 
IR1.Therefore, the orientation of AbiEi binding on the IRs involves the wHTH 
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domains on the conserved outer IR regions and the CTD (which contains the R97 
residue) facing each other in the central region of the extended IRs. 
Discussion  
Here we have revealed the negative autoregulation and DNA binding mechanism 
used by the AbiEi antitoxin. This is the first example of autoregulation in a Type IV 
TA system. Based on our data, we propose a model where the wHTH domain of 
AbiEi binds to the highly conserved external 11 bp of the inverted repeat and the 
positively charged CTD interacts with the remaining imperfect 12 bp palindrome to 
stabilize the AbiEi-DNA interaction (Fig. 6). Binding of the first AbiEi monomer to 
either IR1 or IR2 acts cooperatively to increase the binding of a second AbiEi 
monomer to the unoccupied IR. When AbiEi is bound to both inverted repeats the 
operator region is bent by 72. We propose that DNA bending improves the position 
of the positively charged face of the CTD for better contact with the inverted repeats. 
It is also possible that the DNA bending assists in protein-protein interactions 
between the AbiEi CTDs to contribute to cooperativity. The net effect of AbiEi binding 
and DNA bending is blocking access of RNA polymerase to the promoter resulting in 
repression of abiE operon expression. 
Most current examples of TA regulation are from Type II systems, which typically 
involves the antitoxins (sometimes in complex with their cognate toxins) binding via 
their DNA-binding NTDs to IR-based operator sequences within the promoter region, 
to repress transcription [30-32,37]. A similar N-terminal DNA binding domain (i.e. the 
wHTH) is observed in the Type IV AbiE system, yet the additional requirement of the 
AbiEi CTD in both negative autoregulation and antitoxicity makes this system unique. 
Inverted repeats are present upstream of other AbiEi homologues, indicating they 
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are a conserved feature of AbiE systems [7]. For example, upstream of rv2827c in 
M. tuberculosis we identified 24 bp near-identical inverted repeats separated by 13 
bp. Autoregulation of Type II systems is important for maintaining the cellular ratios 
of toxin to antitoxin [15] and it is likely that the Type IV AbiE negative autoregulation 
fulfils a similar function.  
DNA bending is likely to contribute to the cooperativity observed for AbiEi binding to 
the abiE promoter region. Similarly, autoregulation by the Type II TA system HipBA 
results from a complex of antitoxin and toxin, binding to four operator regions 
upstream of the hipBA operon and inducing a 70 bend. This bending results in 
better alignment of the recognition helices, which is proposed to aid HipBA 
cooperative binding to additional operator regions [38]. Therefore, we propose that 
DNA bending by AbiEi facilitates the observed cooperativity. In addition, 
cooperativity might involve protein-protein interactions, and although the structure of 
the M. tuberculosis Rv2827c AbiEi homologue did not reveal a dimerization interface 
[29], the region in the extreme CTD that could not be confidently modelled may 
contribute. The obligate cooperativity of R100A (and R44A) suggests that when both 
inverted repeats are occupied by AbiEi, their interaction is further stabilized, by 
bending of the operator DNA. Because cooperativity was not altered in other SDMs, 
the positive charge is not the main factor contributing to cooperativity. In addition, 
nucleotide-specific interactions are occurring, due to the observed differences in 
AbiEi R97A stability with the two IRs. High resolution structures of AbiEi in solution 
and in complex with single or double inverted repeats are required to fully resolve the 
basis for precise protein:DNA and potential protein:protein interactions.  
It is noteworthy that Type IV TA systems do not involve direct interaction of the 
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antitoxin and toxin [7,21]. For instance, the outcome of Type II TA autoregulation 
often depends on the antitoxin to toxin ratio and the strength of repression is defined 
by differences in binding affinities of the antitoxin alone or complexes of antitoxin and 
toxin [16,39]. In this process of conditional cooperativity, high levels of toxin can then 
destabilize repression by disrupting cooperativity, causing derepression and 
reestablishment of antitoxin to sequester the excess toxin [30,40]. As might be 
expected for Type IV TA systems, where the toxin and antitoxin do not interact [22], 
AbiEii toxin expression caused no further repression of the abiE promoter in the 
presence of AbiEi [7]. Thus, it appears that the CTD of AbiEi has evolved dual 
functionality to assist in the cooperative autoregulation of the abiE operon whilst also 
fulfilling its other role as an antitoxin.  
Recently, antitoxins from Type II TA systems were shown to regulate the expression 
of additional genes, outside their own operons, such as those involved in biofilm 
formation [41-43]. Therefore, it is possible that analogous physiological and 
metabolic regulation is provided by S. agalactiae AbiEi and related Type IV 
homologues. In support of this, the Rv2827c homologue in M. tuberculosis is 
important for cell replication [44], and its expression is upregulated upon exposure to 
the first line M. tuberculosis drugs isoniazid and streptomycin, and during starvation 
conditions [45]. The S. agalactiae abiE operon resides on an integrative and 
conjugative element (ICESa2603rplL) that encodes genes for both metal resistance 
and virulence [46]. In addition to providing phage resistance, AbiE is likely to have a 
role in maintenance of this pathogenicity island similar to MosAT in Vibrio cholerae 
[7,28]. AbiE family members are widespread, not just amongst clinically relevant 
species but throughout almost all bacterial clades. Therefore, it is likely that the 
classical TA function (stabilisation of mobile genetic elements), Abi system function 
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(phage resistance) and antitoxin-facilitated physiological regulation provided by AbiE 
proteins contributes significantly to shaping the physiology and evolution of many 
bacteria. 
Materials and Methods 
Bacterial strains and culture conditions 
Escherichia coli strains DH5 and BL21 were grown at 37°C in lysogeny broth (LB) 
with shaking at 200 rpm or on LB containing 1.5% (w/v) agar (LBA). When relevant, 
media were supplemented with the following antibiotics and supplements: 100 μg/ml 
ampicillin (Ap); 50 μg/ml kanamycin (Km); 10 μg/ml tetracycline (Tc); 50 μg/ml 
streptomycin (Sm); 0.1% (w/v) L-arabinose (ara), 0.2% (w/v) D-glucose (glu) and 10 
µM isopropyl-β-D-thiogalactopyranoside (IPTG). Bacterial cell density was measured 
in a Jenway 6300 spectrophotometer at 600 nm (OD600).  
Structural modeling and sequence analysis 
DNA sequence analyses were performed using Geneious 9.0.5 software [47] and 
BLAST (nucleotide and protein) [48] was used for sequence identification. A 
structural model of AbiEi was generated using Phyre2, based on the PDB:1ZEL 
template [33]. To assist in selection of mutants, we aligned the AbiEi model with a 
template model of DNA-bound Rv2827c kindly provided by Manfred Weiss [29]. 
Protein structure coordinate files were obtained from the Protein Data Bank (PDB) 
(http://www.rcsb.org/pdb) and visualized using PyMOL (http://www.pymol.org). The 
solvent-accessible electrostatic surface potential was calculated using APBS [49].  
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DNA isolation and manipulation 
All oligonucleotides used are outlined in Table S1. Plasmid DNA was isolated using 
the Zyppy Plasmid Miniprep Kit (Zymo Research). All plasmids are listed in Table 1 
and were confirmed by DNA sequencing. Restriction digests, ligations, 
transformation of E. coli and agarose gel electrophoresis were performed by 
standard techniques (Sambrook et al., 1989). DNA from PCR and agarose gels was 
purified using the Illustra GFX PCR DNA and Gel Band urification Kit (GE 
Healthcare). Restriction enzymes and T4 ligase were from Roche or New England 
Biolabs. 
abiE promoter activity assays 
E. coli strains carrying plasmids expressing the various AbiEi mutants were 
transformed with a plasmid containing ~200 bp of promoter sequence fused to a lacZ 
reporter gene (pRLD32). Strains were grown in 1.2 ml of LB with appropriate 
antibiotics within individual wells of Labcon deep 96 square well plates. Plates were 
incubated with 12,000 rpm shaking at 37°C using a microplate shaker (IncuMix, 
BioProducts). Expression analysis was performed using the fluorogenic -
galactosidase substrate: 4-Methylumbelliferyl-D-galactoside (MUG) [50,51]. Samples 
of 100 l were extracted at specific time points and frozen in separate 96-well 
microtiter plates at −80°C. Samples were defrosted by incubation at 37°C for 10 min. 
Ten l volumes of each sample were subsequently frozen at −80°C and immediately 
prior to the assay thawed for 10 min at 37°C. During this time the final reaction buffer 
(PBS, 2 mg/ml
   
lysozyme, 250 µg/ml MUG) was prepared, from which 100 l was 
added to the thawed samples. The relative change in fluorescence was immediately 
monitored using a Varioskan Flash Multimode Reader (Thermo Fisher Scientific) 
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according to the following parameters: excitation 365 nm, emission 455 nm, 37°C, 8 
reads per well, measured every 1 min for 30 min. Relative fluorescent units (RFUs) 
per second were calculated using the linear increase in fluorescence which was 
normalized to the OD600 of the sample (RFU/s/OD600). -gal activity was normalized 
to the native promoter activity (at 100%).  
Toxicity/Antitoxicity assays 
The toxicity of AbiEii was determined as previously described [7] using an inducible 
expression plasmid containing the toxin gene, abiEii, under the control of the 
stringent araBAD promoter [52]. Using this setup, expression of AbiEii is repressed 
in the presence of glucose and inducible with the addition of arabinose [7,52]. For 
antitoxicity assays, the AbiEi expression constructs, under control of the T5/Lac 
promoter, were tested for their ability to abrogate AbiEii-mediated toxicity. E. coli 
cultures were grown overnight in a Labcon deep 96 square well plate at 12,000 rpm 
at 37°C using an orbital plate shaker (IncuMix, BioProducts). These were 
subcultured into a fresh deep well plate containing 1.2 ml LB, Ap, Sp and glu per well 
at a starting OD600 of 0.05. After 3 h of growth at 37°C with shaking at 12,000 rpm, 
bacteria were pelleted, washed twice and a dilution series was performed in 
phosphate buffered saline (PBS). Toxicity was quantitated by plating the dilution 
series onto LBA, Ap, Sp plates supplemented with: i. glu only; ii. ara only and iii. ara 
and IPTG. After overnight incubation at 37°C the colony forming units (CFU) were 
determined for each treatment and the antitoxicity activity determined as [log(CFU+ara 
+IPTG) – log(CFU+ara)]/[log(CFU+glu)-log(CFU+ara)] x 100%. The antitoxicity activity in 
the absence of AbiEi expression (-ve control) is, by definition, 0%.  
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Protein expression and purification 
Briefly, E. coli BL21, pPF1087 (His6-Linker-TEV-AbiE, or a plasmid containing a 
SDM in AbiEi), pRARE was grown with LB and Ap, subcultured 1:100 in 100 ml in 1 
L flasks and grown at 25°C at 200 rpm. For expression of some SDMs (from 
plasmids pPF1221 (R44A:R66A), pPF1225 (K69A) and pPF1226 (R97A)) an E. coli 
BW25116 lon, pRARE strain was used to increase yield. When an OD600 of ~0.5 
was reached, protein expression was induced with 1 mM IPTG and cultures were 
incubated overnight at 25°C at 200 rpm. Cells were harvested by centrifugation at 
3,000 g at 4°C. The cell pellets were resuspended in 5 ml of equilibration buffer (10 
mM HEPES-NaOH pH 7.5, 300 mM NaCl, 5 mM imidazole, and cOmplete mini 
EDTA-free protease inhibitor cocktail (Roche)). Cells were lysed by a total of 4 min 
sonication in 10 s pulses at an amplitude of 30%. The cell lysate was clarified by 
centrifugation at 10,000 g at 4°C for 15 min.  
The clarified lysate was loaded on to a 1 ml bed volume of Ni-NTA resin (Protino) 
equilibrated with equilibration buffer. Unbound proteins were removed by washing 
with 20 column volumes of wash buffer (10 mM HEPES-NaOH pH 7.5, 300 mM 
NaCl, 20 mM imidazole) followed by 5 column volumes of low imidazole elution 
buffer (10 mM HEPES-NaOH pH 7.5, 300 mM NaCl, 75 mM imidazole). Proteins 
bound to the resin were eluted using 5 column volumes of high imidazole elution 
buffer (10 mM HEPES-NaOH pH 7.5, 300 mM NaCl, 250 mM imidazole). Fractions 
were analyzed on 12% SDS-PAGE gels by Coomassie blue stain. Fractions of 
interest were pooled into dialysis tubing (SnakeSkin, 3500 MWCO, Thermo 
Scientific) and TEV protease was added. Samples were then dialyzed overnight in 
10 mM HEPES-NaOH, pH 7.5, 300 mM NaCl, 5 mM imidazole and 1 mM DTT 
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(dialysis buffer). To remove the cleaved His6 tag, post-cleavage samples were run 
over a 1 ml bed volume of Ni-NTA resin (Protino) using 5 bed volumes of wash 
buffer. Fractions were analyzed on 12% SDS-PAGE gels by Coomassie blue stain. 
Fractions of interest were concentrated down to 500 µl using Ultra 4 Centrifugal 
filters, Ultracel 10K (Amicon). Concentrated samples had 250 µl of storage buffer 
added (10 mM HEPES, 150 mM NaCl, 70% (v/v) glycerol). Aliquots of protein were 
then snap frozen using dry ice and ethanol and stored at -80°C.  
Electrophoretic Mobility Shift Assays 
A 175 bp promoter region was amplified by PCR using primers PF1150 and PF2081 
(5’ IRDye 700) for fluorescently labeled DNA, and PF1150 and PF2178 for 
unlabeled DNA. The templates contained either the native promoter region with both 
inverted repeats (pRLD32) or mutated versions lacking one or both of the predicted 
AbiEi binding sites (pRLD65, pRLD67 or pRLD68). A short fluorescent duplex 
(PF2379) was used for the 23 bp operator probe. For the probe containing a spacer 
between the two operator sites a gBlock (PF2380, Integrated DNA Technologies) 
was used as template for PCR. All DNA substrates were gel purified and the AbiEi 
proteins were purified as described above. Binding reactions contained 8 μl binding 
buffer (5 mM HEPES pH 7.6, 0.25 mM EDTA, 2.5 mM (NH4)2SO4, 0.25 mM DTT, 
0.05% (w/v) Tween 20, 7.5 mM KCl, 3.1 mM MgCl2, 0.5 μg Poly[d(I-C)] (Roche), 50 
ng Poly L-lysine (Roche), 10 μg BSA), 1 μl fluorescently labeled DNA (35 fmol) and 1 
μl AbiEi protein diluted with dialysis buffer. For assays involving specific (native 
promoter) and non-specific (promoter with both binding sites mutated) competition, 
100-fold excess unlabeled DNA (3.5 pmol) was included. Reactions were incubated 
at room temperature for 15 min and then run on 0.5X TBE 6% polyacrylamide gels 
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(4% polyacrylamide gels for probe containing a spacer) at 200 V and 4ºC. 
Fluorescence was measured using the OdysseyR Fc Dual mode imaging system (LI-
COR) at 700 nm. Bands intensities were quantified using Image Systems software 
(LI-COR) and were used to determine the proportion of occupied DNA binding sites 
(Y). Apparent dissociation constants (Kd) were determined from nonlinear regression 
fits of the data according to a single site binding model in GraphPad Prism version 
6.0. The Kd was derived from the following equation Kd = [P]nH((1-Y)/Y), where Kd is 
the apparent dissociation constant, [P] is the protein concentration, nH is the Hill 
constant, and Y is the proportion of occupied binding sites. The Hill constant is the 
gradient of the Hill plot slope and was determined using GraphPad Prism version 
6.0. Mean and standard error of the mean (SEM) values are derived from at least 
three independent experiments.  
DNA bending assays 
Equal sized DNA fragments containing the two AbiE IRs were generated by PCR 
using pPF1401 as a template and the following primer pairs; PF2839 and PF2840, 
PF2841 and PF2842, PF2843 and PF2844, PF2845 and PF2846, and PF2847 and 
PF2848. DNA fragments were gel purified and resulted in five DNA fragments 
containing the AbiEi IRs positioned differently with respects to the ends. Binding 
reactions contained 8 μl binding buffer (5 mM HEPES pH 7.6, 0.25 mM EDTA, 2.5 
mM (NH4)2SO4, 0.25 mM DTT, 0.05% (w/v) Tween 20, 7.5 mM KCl, 3.1 mM MgCl2, 
10 μg BSA), 1 μl template DNA (36.3 fmol) and 50 nM AbiEi protein diluted with 
dialysis buffer. Reactions were incubated at room temperature for 15 min and then 
run on 0.5X TBE 6% polyacrylamide gels at 200 V and 4ºC. Gels were stained for 15 
min in SYBR gold, and then imaged using the OdysseyR Fc Dual mode imaging 
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system (LI-COR) at 600 nm. The relative mobility of DNA fragments with or without 
protein was used to estimate the bend angle, , using the formulae, a= -b= 2c (1-cos 
) as previously described [53].  
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Figure Legends  
 
Fig. 1. The positively charged surface of AbiEi. (A) Solvent-accessible 
electrostatic surface of the M. tuberculosis AbiEi homologue, Rv2827c (PDB:1ZEL), 
coloured by electrostatic potential (blue is positive and red negative). (B) Solvent-
accessible surface of the S. agalactiae AbiEi model structure, coloured by 
electrostatic potential, showing the predicted DNA-binding positively charged (blue) 
surface and opposing, negatively charged (red) face. Note that the final 41 resides of 
the CTD could not be confidently modelled. (C) Phyre2-generated sequence 
alignment between AbiEi and Rv2827c, used to generate the AbiEi model, showing 
the predicted secondary structure for AbiEi. Residues that were selected for 
mutagenesis are coloured either orange (lysine) or green (arginine). (D) The 
predicted DNA-binding face of AbiEi with mutated residues coloured as in (C). (E) 
Model for the interaction of the wHTH domain of AbiEi with DNA, based on Janowski 
et al 2009 [29] with mutated residues coloured as in (C).  
 
Fig. 2. Autoregulation and antitoxicity for the surface charge depleted single 
mutants. (A) Schematic of AbiE inverted repeats 1 and 2 (IR1, IR2), with regards to 
the -35, -10, ribosome binding sites (RBS) and the start codon (M). Solid arrow 
shows the conserved 11 bp, while dotted arrow shows the partially conserved 
regions of the inverted repeats. Sequence differences between the partially 
conserved regions are shown in red. (B) Schematic of the autoregulation assay, 
showing AbiEi binding the abiE operator inverted repeats and suppressing lacZ 
expression. (C) Autoregulation by single alanine substitution mutants of AbiEi, 
measured using a lacZ reporter assay. The -gal activity observed for each mutant 
was normalized to the non-repressed abiE promoter activity observed in the absence 
of AbiEi (-ve). (D) Schematic of the antitoxicity assay. (E) Antitoxicity capability of 
WT AbiEi and each of the single mutants. Data shown are the means and error bars 
represent the SEM (n=3). 
 
Fig. 3. The positively charged face of the CTD is required for negative 
autoregulation. (A) Autoregulation by the double and triple mutants of AbiEi, 
measured using a lacZ reporter assay as described in Fig. 2 (B) Antitoxicity 
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capability of WT AbiEi and each of the double and triple mutants. Data shown are 
the means and error bars represent the SEM (n=3). 
 
Fig. 4. AbiEi cooperatively binds and bends the abiE operator. Electrophoretic 
mobility shift assays performed using WT AbiEi, with a fluorescently labeled probe 
containing either (A) the native abiE promoter region, or mutated operator 
sequences where either (B) IR1, (C) IR2 or (D) both IR1 and IR2 were replaced by 
cytosines. The schematics to the right of each gel image depict the DNA constructs 
used in each experiment. The concentration of AbiEi was increased from 0.78 to 50 
nM in 2-fold steps. The labels indicate (N) non-shifted, (1) single shifted and (2) 
double shifted bands. The lanes denoted (S) and (NS) indicate competition by 100-
fold molar excess of unlabeled specific DNA or non-specific DNA, respectively, with 
25 nM AbiEi. The (E) binding curve, (F) Hill plot and (G) Scatchard plot for the 
interaction of AbiEi with the native abiE promoter, as represented in (A). EMSAs 
were carried out using a short fluorescent probe, (H) containing only one inverted 
repeat, and (I) using a probe with a 50 bp spacer inserted between the two inverted 
repeats. The (J) binding curve, (K) Hill plot and (L) Scatchard plot for the interaction 
of AbiEi with the fluorescent probe containing a linker between the inverted repeats 
as seen in (I). (M) a representative DNA bending assay using WT AbiEi at 50 nM. 
Schematic shows the DNA probe in black, with the relative IR location in red. (N) The 
DNA bending curve shows the relative mobility of the fragments based on the 
location of the AbiEi binding sites and was used to calculate the bending angles. All 
EMSAs were performed at least three times, graphs and error bars represent the 
mean  SEM. 
 
Fig. 5. Impaired DNA binding by the AbiEi mutants. Electrophoretic mobility shift 
assays were performed using either WT AbiEi or the (A) specified single or (B) 
double mutants with a fluorescently labeled probe comprising the native abiE 
promoter region. The (C) R100A and (D) R97A mutants were also tested in EMSAs 
when either IR1 or IR2 were replaced with cytosines. The labels indicate (N) non-
shifted or (1) single shifted. The concentration of AbiEi was increased from 0.78 up 
to 50 nM in 2-fold steps. Apparent Kd values are the mean  SEM (n=3). The label 
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cooperative indicates AbiEi binding is cooperative and ND indicates no Kd could be 
calculated. Refer to Fig. S2 for Kd curves, Hill and Scatchard plots.  
 
Fig. 6. Model for AbiEi autoregulation via binding to IRs in the abiE promoter 
region. Binding of one AbiEi monomer to IR1 or IR2 has an apparent Kd of 7.9  1.2 
or 7.4  1.2 respectively. The NTD binds to the highly conserved 11 bp (black boxes) 
with the CTD binding to the lesser conserved region containing 4 mismatches (grey 
boxes). The binding of a second AbiEi is cooperative (i.e. increased likelihood 
following the binding of the first AbiEi monomer), and this exhibits an apparent Kd of 
10.8  0.7. This results in a bend in the DNA of 72  2, and also the transcriptional 
repression of the AbiEi operator, most likely due occlusion of the RNA polymerase 
through blocking the -35 and -10 promoter elements.   
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Table 1. Plasmids used in this study 
 
 
Plasmid Genotype/Phenotype Reference 
pBAD30 E. coli arabinose inducible vector, Ap
R, 
pACYC184/p15A replicon 
[39] 
pTA100 pQE-80L derivative with Sm/Sp resistant cassette, 
Sm/SpR, ColE1 replicon 
[8] 
pRW50 Promoterless lacZ fusion plasmid, Tc
R, RK2 
replicon 
[53]  
pRARE E. coli rare tRNA, pACYC-184 derivative, Cm
R, 
p15A replicon 
[54] 
pRLD12 Native AbiEii, pBAD30-derivative, ApR  [7] 
pRLD13 Native AbiEi, pTA100-derivative, SmR/SpR [7]  
pRLD32 PabiE lacZ fusion (-72 to +50) pRW50 derivative, 
TcR 
[7]  
pRLD65 S. agalactiae V/R 2603 PabiE 100bp, IR 1 replaced 
with C 
 
[7] 
pRLD67 Streptococcus agalactiae V/R 2603 PabiE 100 bp, 
IR2 replaced with C 
[7] 
pRLD68 Streptococcus agalactiae V/R 2603 PabiE 100 bp, 
IR1 and 2 replaced with C 
 
[7] 
pPF1067 pQE80L-oriT, N terminal His6 with TEV cleavage 
site 
This study 
   
Untagged AbiEi SDMs   
pPF627 K3A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF628 K4A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF1145 K13A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF629 K21A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF630 K24A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF665 R35A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF631 K38A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF632 R44A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF633 K47A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF634 R66A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF635 K69A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF1146 R97A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF636 R100A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF1147 K115A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF637 R134A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF1148 R149A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF1149 K151A AbiEi,  pTA100-derivative, SmR/SpR This study 
pPF668 K159A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF669 K169A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF670 K170A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF671 K174A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF672 K181A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF673 K187A AbiEi, pTA100-derivative, SmR/SpR This study 
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pPF674 K189A AbiEi, pTA100-derivative, SmR/SpR This study 
   
pPF701 R44A:R100A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF702 R44A:R66A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF757 K159A:K170A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF759 K170A:K181A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF761 K181A:K189A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF764 R66A:R100A AbiEi, pTA100-derivative, SmR/SpR This study 
pPF768 
K170A:K181A:K189A AbiEi, pTA100-derivative, 
SmR/SpR 
This study 
pPF1308 K69A:R100A AbiEi, pTA100-derivative SmR/SpR This study 
pPF1309 K69A:R97A AbiEi, pTA100-derivative SmR/SpR This study 
pPF1248 R97A:R100A  AbiEi, pTA100-derivative SmR/SpR This study 
pPF1402 
R44A:R66A:R100A AbiEi, pTA100-derivative 
SmR/SpR 
This study 
   
AbiEi overexpression constructs  
pPF1080 Native AbiEi, pPF1067 derivative, ApR This study 
pPF1140 R35A AbiEi, pPF1067 derivative, ApR This study 
pPF1141 R66A AbiEi, pPF1067 derivative, ApR This study 
pPF1142 R100A AbiEi, pPF1067 derivative, ApR This study 
pPF1143 R140A AbiEi, pPF1067 derivative, ApR This study 
pPF1144 R66A:R100A AbiEi, pPF1067 derivative, ApR This study 
pPF1221 R44A AbiEi, pPF1067 derivative, ApR This study 
pPF1222 K47A AbiEi, pPF1067 derivative, ApR This study 
pPF1223 K69A AbiEi, pPF1067 derivative, ApR This study 
pPF1224 R97A AbiEi, pPF1067 derivative, ApR This study 
pPF1225 R44A:R66A AbiEi, pPF1067 derivative, ApR This study 
pPF1226 R44A:R100A AbiEi, pPF1067 derivative, ApR  This study  
pPF1401 pBend5 containing IR1 and IR2, ApR  
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Highlights 
 
 The Type IV antitoxin AbiEi has a positive surface charge that aids DNA 
binding  
 AbiEi binds cooperatively to two inverted repeats overlapping the abiE 
promoter 
 The AbiEi C-terminal domain binds to the extended region of the inverted 
repeats 
 AbiEi binding causes DNA bending and repression of the abiE toxin-antitoxin 
operon 
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